Literature DB >> 17534967

Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials.

Ralf Kohnen1, Richard P Allen, Heike Benes, Diego Garcia-Borreguero, Wayne A Hening, Karin Stiasny-Kolster, Marco Zucconi.   

Abstract

The Restless Legs Syndrome (RLS) is a sensorimotor disorder that has only recently been extensively investigated by validated methods. Following the first presentation of diagnostic criteria by the International RLS Study Group in 1995, several methods were specifically developed for clinical trials in RLS or adapted from other areas of medicine and health sciences. We present a critical overview on validated methods to assess (1) severity of RLS symptoms [International RLS Rating Scale (IRLS), John Hopkins RLS Severity Scale (JHRLSSS), the RLS-6 scales, and the investigator-based Clincial Global Impressions (CGI)]; (2) quality of life [RLS Quality of Life Instrument (RLS-QLI), Hopkins RLS Quality of Life Questionnaire (RLSQoL), and the RLS Quality of Life Questionnaire (QoL-RLS)]; (3) sleep disturbances and sudden onset of sleep; (4) sleep laboratory methods (polysomnography, limb activity monitoring by actigraphy) to evaluate sleep and periodic leg movements (including the "suggested immobilization test"); and (5) severity of augmentation (Augmentation Severity Rating Scale, ASRS). It is concluded that several validated methods are available to investigate the main features of RLS in practice and in clinical trials; however, further developments are needed to address new questions like the consequences of RLS on life functioning in areas such as ability to travel, days missed at work or impaired work performance.

Entities:  

Mesh:

Year:  2007        PMID: 17534967     DOI: 10.1002/mds.21588

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Efficacy of an eight-week yoga intervention on symptoms of restless legs syndrome (RLS): a pilot study.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal; Kimberly Williams; Kathryn L Flack
Journal:  J Altern Complement Med       Date:  2012-12-27       Impact factor: 2.579

3.  Cannabis Use for Restless Legs Syndrome and Uremic Pruritus in in patients treated with maintenance dialysis: A Survey.

Authors:  Daniel Samaha; Trisha Kandiah; Deborah Zimmerman
Journal:  Can J Kidney Health Dis       Date:  2020-09-10

4.  Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).

Authors:  William G Ondo; Frank Grieger; Kimberly Moran; Ralf Kohnen; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

5.  Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial.

Authors:  Kim E Innes; Terry Kit Selfe; Caitlin Montgomery; Nicole Hollingshead; Zenzi Huysmans; Roshini Srinivasan; Sijin Wen; Madeleine J Hausmann; Karen Sherman; Maryanna Klatt
Journal:  J Clin Sleep Med       Date:  2020-01-15       Impact factor: 4.062

6.  Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome.

Authors:  Ulrike H Mitchell
Journal:  Neuropsychiatr Dis Treat       Date:  2011-05-06       Impact factor: 2.570

Review 7.  Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?

Authors:  Akito Kume
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-03       Impact factor: 2.570

8.  Sleep-onset time variability and sleep characteristics on weekday and weekend nights in patients with COPD.

Authors:  Daniele Caroline Dala Pola; Raquel Pastrello Hirata; Lorena Paltanin Schneider; Mariana Pereira Bertoche; Karina Couto Furlanetto; Arthur Eumann Mesas; Fabio Pitta
Journal:  J Bras Pneumol       Date:  2022-09-05       Impact factor: 2.800

9.  Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease).

Authors:  Diego Garcia-Borreguero; Ralf Kohnen; Lindsay Boothby; Desislava Tzonova; Oscar Larrosa; Elmar Dunkl
Journal:  Sleep       Date:  2013-07-01       Impact factor: 5.849

10.  Restless legs syndrome: differential diagnosis and management with rotigotine.

Authors:  Giovanni Merlino; Anna Serafini; Francesca Robiony; Mariarosaria Valente; Gian Luigi Gigli
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.